⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
COGT News
Cogent Biosciences, Inc. Common Stock
Form 8-K
sec.gov
COGT
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2026 Financial Results
globenewswire.com
COGT
Cogent Biosciences to Participate in the Guggenheim Healthcare Innovation Conference
globenewswire.com
COGT
Cogent Launches Attack Path Analysis to Counter Rogue AI Agent Swarms
prnewswire.com
COGT
GOOG
COIN
Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) for Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
globenewswire.com
COGT
Form 8-K
sec.gov
COGT
Form 8-K
sec.gov
COGT
Form 8-K
sec.gov
COGT
Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM)
globenewswire.com
COGT
Cogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematology Association (EHA) Congress
globenewswire.com
COGT